COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)

Since the emergence of the SARS-CoV-2 infection, many recommendations have been made. However, the very specific nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against Cancers and leukemias in chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouger-Gaudichon, Jérémie, Bertrand, Yves, Boissel, Nicolas, Brethon, Benoit, Ducassou, Stéphane, Gandemer, Virginie, Halfon-Domenech, Carine, Leblanc, Thierry, Leverger, Guy, Michel, Gérard, Petit, Arnaud, Ray-Lunven, Anne-France, Rohrlich, Pierre-Simon, Schneider, Pascale, Sirvent, Nicolas, Strullu, Marion, Baruchel, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société Française du Cancer. Published by Elsevier Masson SAS. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951944/
https://www.ncbi.nlm.nih.gov/pubmed/33781551
http://dx.doi.org/10.1016/j.bulcan.2021.02.004
Descripción
Sumario:Since the emergence of the SARS-CoV-2 infection, many recommendations have been made. However, the very specific nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE) to propose more specific recommendations. Here is the second version of these recommendations updated according to the evolution of knowledge on COVID19.

Ejemplares similares